Skip to content

Antihypertensive treatment in patients of spontaneous intracerebral hemorrhage with cerebrovascular stenosis trial (ATIST)

Antihypertensive treatment in patients of spontaneous intracerebral hemorrhage with cerebrovascular stenosis trial (ATIST)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010675
Enrollment
Unknown
Registered
2017-02-18
Start date
2017-01-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spontaneous intracerebral hemorrhage

Interventions

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years old and more; 2. within 6 hours of symptom onset; 3. Acute primary ICH, hematoma in brain parenchyma or intraventricular extension, rarely into SAH, verified by CT or MRI; 4. Cerebrovascular luminal narrowing (25%-75%) demonstrated with CTA; 5. SBP is from 150 to 220mmHg (twice repeat measurements, record = 2min apart); 6. Agree to participate in this clinic trail and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Known definite indication to antihypertensive treatment (e.g. very high systolic blood pressure N220 mm Hg; hypertensive encephalopathy; aortic dissection); 2. known definite contraindication to antihypertensive treatment (e.g. the high blood pressure is caused by the increasing of the intracranial pressure which is called Cushing's response; severe cerebrovascular stenosis, severe renal failure); 3. The intracerebral hemorrhage is caused by secondary factors (e.g. intracranial aneurysm; arteriovenous malformation; tumor stroke); 4. anticoagulant correlation hemorrhage; 5. History of ischemic stroke within 30 days before SICH; 6. GCS = 5 or deep coma; 7. Disabled or with underlying diseases (e.g. known dementia, severe cardiovascular disease, kidney failure) before onset; 8. Known indication of emergency surgery (volume of supratentorial hematoma =30ml or volume of infratentorial hematoma =10ml; within 48 hours from onset; GCS=5)

Design outcomes

Primary

MeasureTime frame
combined endpoin tof death and dependence;incidence of ischemic stroke;Health related quality of life index;

Countries

China

Contacts

Public ContactChao You

West China Hospital, Sichuan University

youchao@vip.126.com+86 18980601505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026